文献速递精神分裂症与精神病性障碍

AVATAR疗法治疗精神病患者听幻觉:单盲随机对照试验

AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial.
PubMed 文献 · Lancet Psychiatry · 2017-11-23

该单盲随机对照试验在单一临床中心纳入150例持续听幻觉患者,比较AVATAR疗法与支持性咨询。

要点

  • AVATAR疗法在12周时减少持续听幻觉严重程度优于支持性咨询。
  • 研究为单中心、单盲设计,样本150例,结果需多中心验证。
  • 未发现归因于AVATAR疗法或支持性咨询的不良事件。

核心结论

  • AVATAR疗法在12周时减少持续听幻觉严重程度优于支持性咨询,效应量大。

研究设计与样本

  • 单盲随机对照试验,在South London and Maudsley NHS Trust单一临床地点进行。
  • 纳入18至65岁、符合ICD10 F20-29或F30-39伴精神病性症状且持续听幻觉至少12个月的患者。
  • 150例按1:1随机分配至AVATAR疗法(n=75)或支持性咨询(n=75),评估者设盲。

主要发现

  • 124例(83%)完成主要结局评估。
  • 未发现归因于任一疗法的不良事件。

关键数值与推荐

  • 主要结局为12周时PSYRATS-AH总分变化,采用意向性分析线性混合模型。
  • 试验前瞻性注册于ISRCTN,注册号65314790。

临床怎么用

  • AVATAR疗法可作为持续听幻觉心理治疗的一种选择,但需多中心研究确认有效性。

局限性

  • 研究为单中心设计,样本量150例,结果外推需谨慎。
  • 需未来多中心研究确立AVATAR疗法的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A quarter of people with psychotic conditions experience persistent auditory verbal hallucinations, despite treatment. AVATAR therapy (invented by Julian Leff in 2008) is a new approach in which people who hear voices have a dialogue with a digital representation (avatar) of their presumed persecutor, voiced by the therapist so that the avatar responds by becoming less hostile and concedes power over the course of therapy. We aimed to investigate the effect of AVATAR therapy on auditory verbal hallucinations, compared with a supportive counselling control condition. METHODS: We did this single-blind, randomised controlled trial at a single clinical location (South London and Maudsley NHS Trust). Participants were aged 18 to 65 years, had a clinical diagnosis of a schizophrenia spectrum (ICD10 F20-29) or affective disorder (F30-39 with psychotic symptoms), and had enduring auditory verbal hallucinations during the previous 12 months, despite continued treatment. Participants were randomly assigned (1:1) to receive AVATAR therapy or supportive counselling with randomised permuted blocks (block size randomly varying between two and six). Assessments were done at baseline, 12 weeks, and 24 weeks, by research assessors who were masked to therapy allocation. The primary outcome was reduction in auditory verbal hallucinations at 12 weeks, measured by total score on the Psychotic Symptoms Rating Scales Auditory Hallucinations (PSYRATS-AH). Analysis was by intention-to-treat with linear mixed models. The trial was prospectively registered with the ISRCTN registry, number 65314790. FINDINGS: Between Nov 1, 2013, and Jan 28, 2016, 394 people were referred to the study, of whom 369 were assessed for eligibility. Of these people, 150 were eligible and were randomly assigned to receive either AVATAR therapy (n=75) or supportive counselling (n=75). 124 (83%) met the primary outcome. The reduction in PSYRATS-AH total score at 12 weeks was significantly greater for AVATAR therapy than for supportive counselling (mean difference -3·82 [SE 1·47], 95% CI -6·70 to -0·94; p<0·0093). There was no evidence of any adverse events attributable to either therapy. INTERPRETATION: To our knowledge, this is the first powered, randomised controlled trial of AVATAR therapy. This brief, targeted therapy was more effective after 12 weeks of treatment than was supportive counselling in reducing the severity of persistent auditory verbal hallucinations, with a large effect size. Future multi-centre studies are needed to establish the effectiveness of AVATAR therapy and, if proven effective, we think it should become an option in the psychological treatment of auditory verbal hallucinations. FUNDING: Wellcome Trust.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Craig TK, Rus-Calafell M, Ward T, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2017. PMID: 29175276. doi:10.1016/S2215-0366(17)30427-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。